E16.0 可计费的具体编码 Drug-induced hypoglycemia without coma
ICD-10-CM E16.0 identifies “Drug-induced hypoglycemia without coma” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
章节 4: Endocrine, nutritional and metabolic diseases
编码说明
Excludes 11
diabetes with hypoglycemia without coma (E09.649)
Use additional code2
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
- code for hypoglycemia level, if applicable (E16.A-)
上级编码说明
章节 4 · Endocrine, nutritional and metabolic diseases (E00-E89)
Excludes 11
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Note1
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
官方索引引用
官方索引引用 (4)
Hypoglycemia(spontaneous) (3)
Reaction (1)
历史
编码历史
最近记录的变更 · FY2025
生效日期
- 编码说明变更
Drug-induced hypoglycemia without coma
可用于账单的诊断编码
CDC/NCHS · FY2025所有版本 (19)
| 所有版本 | 生效日期 | 编码历史 |
|---|---|---|
| FY2016 | 2015-10-01 | 首次收录 |
| FY2017 | 2016-10-01 | 编码说明变更 |
| FY2018 | 2017-10-01 | 编码说明变更 |
| FY2019 | 2018-10-01 | 分类表无变更 |
| FY2020 | 2019-10-01 | 分类表无变更 |
| FY2020 · April | 2020-04-01 | 分类表无变更 |
| FY2021 | 2020-10-01 | 分类表无变更 |
| FY2021 · 01-01 | 2021-01-01 | 分类表无变更 |
| FY2022 | 2021-10-01 | 分类表无变更 |
| FY2022 · 04-01 | 2022-04-01 | 分类表无变更 |
| FY2023 | 2022-10-01 | 分类表无变更 |
| FY2023 · 04-01 | 2023-04-01 | 分类表无变更 |
| FY2024 | 2023-10-01 | 分类表无变更 |
| FY2024 · 04-01 | 2024-04-01 | 分类表无变更 |
| FY2025 | 2024-10-01 | 编码说明变更 |
| FY2025 · 04-01 | 2025-04-01 | 分类表无变更 |
| FY2026 | 2025-10-01 | 分类表无变更 |
| FY2026 · April | 2026-04-01 | 分类表无变更 |
| FY2027 | 2026-10-01 | 分类表无变更 |
历史 ICD-9 映射 · 2018
仅为历史映射,不可自动替换编码。
- 251.1 · 近似
此条目是所选版本中的完整编码。 参考核验不能确定临床适用性,也不保证报销。